James R Berenson, MD
President and CEO – James R. Berenson, M.D., Inc.
Medical & Scientific Director
Institute for Myeloma & Bone Cancer Research (IMBCR)
Chief Executive Officer
Oncotherapeutics
W. Hollywood, CA
Articles
BERENSON ONCOLOGY COULDN’T WAIT TO GET THE CAPILLARYS 2 In-house electrophoresis from Sebia helps ensure superior patient care
Overheard at an outdoor café: “…They said they won’t get the lab results back until next week. I’m really worried. I can’t focus on anything else...I’m a nervous wreck.”
That was part of a real-life conversation between two women having lunch in Atlanta.
Unfortunately, there was nothing unusual about it. Thousands of patients endure the same frightening scenario every year. Read Article PDF
The Beach ReporterAugust 2009 Officer continues cancer fight with treatment, hope
Optimism and hope remain the weapons of choice for Manhattan Beach Police Officer Mark Vasquez as he continues to fight multiple myeloma cancer.
Video Feature July 2009
Dr. Jim Berenson is featured on KTLA-Channel 5’s prime time news segment from Emmy award winning news anchor, Emmett Miller as he follows the story of a courageous young police officer who is battling multiple myeloma.
The Steven Spierer ShowApril 2009
Steve interviews James Tamkin, M.D. who is living with cancer. If you or someone you love is diagnosed with cancer, you gotta hear this show.
Patientpower.comNovember 2007 Hear Dr. Berenson speak on:
Contemporary Issues in Relapsed-Refractory Myeloma
We've been receiving hundreds of questions from myeloma patients. While we can't answer them all, they do tend to cover common ground. We'll address key topics in our next live webcast, the fourth in a series of 7 programs. Join us for our discussion with Dr. James Berenson, Founder, President and CEO of the Institute for Myeloma and Bone Cancer Research. Replay Available here
IONlinkAugust 2006
A Phase I/II Study of Trisenox®, VELCADE® and Ascorbic Acid in Relapsed/Refractory Multiple Myeloma. Read the article...
Oncology TimesAugust 2006
Zoledronic Acid Extends Survival In Lung Cancer & Multiple Myeloma Patients With High Levels of Bone Metabolism. Read the article...
American Cancer SocietyNovember 2005
Safety of Prolonged Therapy with Bortezomib in Relapsed or Refractory Multiple Myeloma Read the article...
Berenson Oncology
9201 Sunset Blvd., Suite 310
West Hollywood, CA 90069
Tel: 310 623.1222
Fax: 310 623.1122